Bahrain approves Wegovy GLP-1 pills for obesity treatment
The National Health Regulatory Authority (NHRA) of Bahrain has approved Wegovy (semaglutide) pills, an oral glucagon-like peptide-1 (GLP-1) treatment for obesity, expanding access to advanced weight-management therapies in the Kingdom. The medicine entered …